Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
2020 · JCI Insight · 497 citations
https://doi.org/10.1172/jci.insight.145207
C
Carolina Alves Costa Silva
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
2.4K
Citations
17
h-index
27
i10-index
Carolina Alves Costa Silva is an academic researcher from Universidade Federal da Bahia. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Gut microbiota and health & COVID-19 Clinical Research Studies. The author has an h-index of 17, co-authored 58 publications.
ORCID: 0000-0003-1920-142XPapers by this author
worksA microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
2023 · Science · 195 citations
https://doi.org/10.1126/science.abo2296
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
2024 · Cell · 142 citations
https://doi.org/10.1016/j.cell.2024.05.029
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
2025 · Cancer Cell · 33 citations
https://doi.org/10.1016/j.ccell.2025.02.010
State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus
2024 · The Lancet Microbe · 29 citations
https://doi.org/10.1016/j.lanmic.2024.07.011
State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus
2024 · The Lancet Microbe · 29 citations
https://doi.org/10.1016/j.lanmic.2024.07.011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat